A Systematic Review and Meta-Analysis of Interventions to Prevent Hepatitis C Virus Infection in People Who Inject Drugs
Open accessThe DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: High rates of hepatitis C virus (HCV) transmission are found in samples of people who inject drugs (PWID) throughout the world. The objective of this paper was to meta-analyze the effects of risk-reduction interventions on HCV seroconversion and identify the most effective intervention types. METHODS: We performed a systematic review and meta-analysis of published and unpublished studies. Eligible studies reported on the association between participation in interventions intended to reduce unsafe drug injection and HCV seroconversion in samples of PWID. RESULTS: The meta-analysis included 26 eligible studies of behavioral interventions, substance-use treatment, syringe access, syringe disinfection, and multicomponent interventions. Interventions using multiple combined strategies reduced risk of seroconversion by 75% (pooled relative risk, .25; 95% confidence interval, .07-.83). Effects of single-method interventions ranged from .6 to 1.6. CONCLUSIONS: Interventions using strategies that combined substance-use treatment and support for safe injection were most effective at reducing HCV seroconversion. Determining the effective dose and combination of interventions for specific subgroups of PWID is a research priority. However, our meta-analysis shows that HCV infection can be prevented in PWID.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among individuals with OUDs, rates of HIV and viral hepatitis are substantially higher than in the general population, implying significantly higher costs to society for individuals with these co-occurring conditions (Hagan, Pouget, & Des Jarlais, 2011; Hess, Hu, Lansky, Mermin, & Hall, 2017).”
From Monetary conversion factors for economic evaluations of substance use disorders (2017) · cites this paper as Hagan, Pouget, & Des Jarlais, 2011
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
Zhang, J., & Yu, K. F. (1998) · JAMA · doi:10.1001/jama.280.19.1690 · Cited by 4,138
Funnel plots for detecting bias in meta-analysis
Sterne, J. A. C., & Egger, M. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00377-8 · Cited by 3,779
The New Zealand Medical Journal 1887-1987.
Rg, R. (1987) · PubMed · Cited by 3,673
QUANTITATIVE METHODS IN THE REVIEW OF EPIDEMIOLOGIC LITERATURE1
GREENLAND, S. (1987) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036298 · Cited by 1,644 · cited 1×
“For 1 study [30] that reported only hazard ratios and P values, CIs were calculated using standard methods [31].”
MethodSharing of drug preparation equipment as a risk factor for hepatitis C
(2001) · American Journal of Public Health · doi:10.2105/ajph.91.1.42 · Cited by 500 · cited 1×
“This finding is consistent with an understanding that an array of factors facilitate HCV transmission among PWID, including the large disease reservoir of HCV-infectious injectors, the efficiency with which HCV may be transmitted via a number of different drug injection–related practices, and the chaotic and rushed at…”
ResultSelf-citationThorpe, L. E. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.7.645 · Cited by 444
ON THE NEED FOR THE RARE DISEASE ASSUMPTION IN CASE-CONTROL STUDIES
GREENLAND, S., & THOMAS, D. C. (1982) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113439 · Cited by 442 · cited 2×
“Even adjusted RRs may not have been calculated following data-based approaches [59], and multivariate models may have included only statistically significant terms and thus omitted important confounding factors [29, 60].”
BackgroundMethod
Research works printed but not linked: 4
- Terrault, 2002, Hepatology (Baltimore, Md.), 36, S99, 10.1002/hep.1840360713 · doi:10.1002/hep.1840360713 · Paper page
- Brunton, 2000, The New Zealand medical journal, 113, 98
- Patrick, 2001, Canadian Medical Association Journal, 165, 889
- Crofts, 1997, Addiction (Abingdon, England), 92, 999, 10.1111/j.1360-0443.1997.tb02979.x · doi:10.1111/j.1360-0443.1997.tb02979.x · Paper page
Cited by
Suryaprasad, A. G., White, J. Z., Xu, F., Eichler, B.-A., Hamilton, J., Patel, A., Hamdounia, S. B., Church, D. R., Barton, K., Fisher, C., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu643 · Cited by 500
“shown to reduce HCV seroconversion by 75% [35].”
BackgroundMartin, N. K., Vickerman, P., Grebely, J., Hellard, M., Hutchinson, S. J., Lima, V. D., Foster, G. R., Dillon, J. F., Goldberg, D. J., Dore, G. J., et al. (2013) · Hepatology · doi:10.1002/hep.26431 · Cited by 488
Luchenski, S., Maguire, N., Aldridge, R. W., Hayward, A., Story, A., Perri, P., Withers, J., Clint, S., Fitzpatrick, S., & Hewett, N. (2018) · The Lancet · doi:10.1016/s0140-6736(17)31959-1 · Cited by 430
Platt, L., Minozzi, S., Reed, J., Vickerman, P., Hagan, H., French, C., Jordan, A., Degenhardt, L., Hope, V., Hutchinson, S., et al. (2018) · Addiction · doi:10.1111/add.14012 · Cited by 362
Self-citationKoh, C., Li, Q., & Liang, J. (2016) · Clinical Virology · doi:10.1128/9781555819439.ch54 · Cited by 321
Metadata
- Authors
- Hagan, H., Pouget, E. R., & Des Jarlais, D. C.
- Affiliations
- New York University (US)
- National Development and Research Institutes (US)
- Venue
- Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-05-31
- Volume
- 204
- Issue
- 1
- Pages
- 74-83
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- PMC
- PMC3105033
- OpenAlex
- W2110957526
- Cited by
- 313
- References
- 62
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 11 · 2023: 9 · 2022: 15 · 2021: 19 · 2020: 19 · 2019: 26 · 2018: 27 · 2017: 32 · 2016: 28 · 2015: 31 · 2014: 31 · 2013: 28 · 2012: 19
- FWCI
- 3.38
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Infectious Diseases (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (R01DA018609, P30 DA121041)
- Topics
- Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- hepatitis C virus, people who inject drugs, HCV seroconversion, harm reduction interventions, syringe access, addiction treatment, behavioral interventions, multicomponent intervention, injection safety
- MeSH terms
- Behavior Therapy, Communicable Disease Control, Hepatitis C, Humans, Substance Abuse, Intravenous, Treatment Outcome, Disease Transmission, Infectious
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Systematic Review and Meta-Analysis of Interventions to Prevent Hepatitis C Virus Infection in People Who Inject Drugs. https://app.cochat.ai/papers/10.1093/infdis/jir196
- The paper
- Hagan, H., Pouget, E. R., & Des Jarlais, D. C. (2011). A Systematic Review and Meta-Analysis of Interventions to Prevent Hepatitis C Virus Infection in People Who Inject Drugs. Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jir196
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.